Accuitive Medical Ventures logo

Accuitive Medical Ventures

North America, Georgia, United States, Duluth

Description

Accuitive Medical Ventures is a Georgia-based venture capital firm established in 2001, specializing in early-stage medical device and technology companies. The firm manages approximately $250 million across two funds, with its first fund closing at $100 million in 2001 and its second at $150 million in 2006. Accuitive's investment thesis has historically centered on identifying innovative technologies with the potential to significantly impact patient care and generate substantial returns.

Over its active investment period, Accuitive Medical Ventures built a portfolio of promising companies, many of which achieved successful exits. Notable examples include Acclarent, a medical device company acquired by Johnson & Johnson for approximately $785 million, and CardioMEMS, which was acquired by St. Jude Medical for $450 million. Another significant exit was Spinal Kinetics, acquired by Orthofix for $45 million. These acquisitions underscore Accuitive's ability to identify and nurture companies that become attractive targets for larger medical corporations.

While Accuitive Medical Ventures has a strong track record of successful investments and exits, its last reported fund close was in 2006, and its most recent investment activity appears to date back to around 2012-2013. This suggests that the firm is likely no longer actively making new first-time investments but is instead focused on managing its existing portfolio, providing follow-on capital where necessary, and pursuing further liquidity events for its remaining holdings.

Investor Profile

Accuitive Medical Ventures has backed more than 53 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 11% of its total and boasts 13 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Medical Device, Biotechnology.

Stage Focus

  • Series B (21%)
  • Series C (21%)
  • Series D (17%)
  • Series Unknown (17%)
  • Series A (8%)
  • Series E (6%)
  • Series G (4%)
  • Debt Financing (4%)
  • Private Equity (2%)
  • Post Ipo Equity (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Manufacturing
  • Health Diagnostics
  • Diabetes
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accuitive Medical Ventures frequently co-invest with?

The Carlyle Group
North America, District of Columbia, United States, Washington
Co-Investments: 16
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 8
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 21
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 11
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 7
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 30
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 5
Investor Growth Capital Limited
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 7
PC
North America, Connecticut, United States, Westport
Co-Investments: 4
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 4

What are some of recent deals done by Accuitive Medical Ventures?

MyoScience

Redwood City, California, United States

MyoScience develops and commercializes technology-driven dermatological products.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownMar 12, 2018
Amount Raised: $10,000,000
Intuity Medical

Fremont, California, United States

Intuity Medical develops blood glucose monitoring systems for diabetes management.

BiotechnologyDiabetesHealth CareMedicalMedical Device
Series UnknownJan 8, 2018
Amount Raised: $70,000,000
Sebacia

Duluth, Georgia, United States

Sebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.

BiotechnologyMedicalMedical Device
Series DJul 25, 2017
Amount Raised: $20,000,000
Neuronetics

Malvern, Pennsylvania, United States

Neuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.

BiotechnologyHealth CareManufacturingMedical DeviceTherapeutics
Series GJun 6, 2017
Amount Raised: $15,000,000
Intuity Medical

Fremont, California, United States

Intuity Medical develops blood glucose monitoring systems for diabetes management.

BiotechnologyDiabetesHealth CareMedicalMedical Device
Series UnknownNov 10, 2016
Amount Raised: $40,000,000
Torax Medical

Saint Paul, Minnesota, United States

Torax Medical develops an implantable device for the treatment of gastroesophageal reflux disease.

BiotechnologyHealth CareMedical Device
Series EJul 26, 2016
Amount Raised: $25,001,500
Sebacia

Duluth, Georgia, United States

Sebacia is a commercial-stage dermatology company that develops an alternative to the topical and systemic drugs for the treatment of acne.

BiotechnologyMedicalMedical Device
Series CJun 25, 2015
Amount Raised: $12,000,000
AcuFocus

Irvine, California, United States

Acufocus is a medical device company that develops and markets KAMRA inlay for the treatment of near vision loss.

Health CareMedicalMedical Device
Series GSep 3, 2014
Amount Raised: $21,000,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Debt FinancingMay 9, 2014
Amount Raised: $2,378,923
Intuity Medical

Fremont, California, United States

Intuity Medical develops blood glucose monitoring systems for diabetes management.

BiotechnologyDiabetesHealth CareMedicalMedical Device
Series UnknownJan 30, 2014
Amount Raised: $5,500,004